ClinicalTrials.Veeva

Menu

Observational Study of TissuePatch SF in Prevention of Air Leaks Following Lung Resection

C

C. R. Bard

Status

Not yet enrolling

Conditions

Post-operative Air Leaks

Treatments

Device: TissuePatch Sealant Film

Study type

Observational

Funder types

Industry

Identifiers

NCT06934486
SUR-25TP001

Details and patient eligibility

About

Post-market, observational study to assess effectiveness of TissuePatch SF in managing/preventing air leaks after lung resection.

Full description

Post-market study conducted to assess the continuing effectiveness and safety of TissuePatch SF when used as an adjunct to standard suture/staple closure of clinically significant (Macchiarini Grade ≥1) intra-operative visceral pleural air leaks incurred during lobectomy and segmentectomy (open or minimally invasive), including those performed as video-assisted thoracic surgery (VATS), in adults.

Enrollment

250 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Is ≥18 and <80 years of age
  2. Undergoing planned (not emergent) video-assisted thoracic surgery pulmonary resection
  3. Understands and is willing to comply with all study related procedures
  4. Has provided signed informed consent

Exclusion criteria

  1. Women who are pregnant or lactating or, if of childbearing potential, are unwilling to use birth control for 6-months following surgery
  2. Has severe congestive heart failure, pulmonary or renal failure, serious haematological disorder or significant liver disease
  3. Has previously undergone a pneumonectomy
  4. Has a bronchial fistula
  5. Has or is suspected of having an active infection at or near the planned surgical site
  6. Has a known allergy or sensitization to TissuePatch SF or its constituent components
  7. In the investigator's opinion, has a life expectancy of less than 12 months
  8. Has, in the investigator's opinion, any disease or condition, physical or psychological, that could interfere with the evaluation of TissuePatch SF or compliance with study procedures

Intra-Operative Exclusion Criteria:

  1. >3 identified air leaks
  2. No air leaks Macchiarini Grade ≥1

Trial design

250 participants in 1 patient group

Patients with intra-operative air leak detected during lung resection
Treatment:
Device: TissuePatch Sealant Film

Trial contacts and locations

0

Loading...

Central trial contact

Director of Clinical Affairs

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems